Received: 18 July 2019
Accepted: 25 June 2020
First Online: 3 July 2020
Ethics approval and consent to participate
: All patients that participated to this study gave their free and informed writing consent. The study was approved by the Institucional Hospital Evita Pueblo Comitee and the COBIMED (Comité de Bioética y Ética de la Investigación de la Facultad de Ciencias Médicas de la Universidad Nacional de La Plata) and the institutional review boards of Saint-Louis Hospital, Paris. The cell line RCC7 was derived by A. Caignard in 2005 (31) and no further ethics approval was required.
: Not applicable.
: The authors declare no potential conflicts of interest.